| Basics |
Savara Inc.
Savara Inc is a pharmaceutical company. The company develops novel therapies for the treatment of serious or life-threatening rare respiratory diseases.
|
| IPO Date: |
March 11, 2013 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$731.1M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 3.12%
|
| Avg Daily Range (30 D): |
$0.07 | 1.87%
|
| Avg Daily Range (90 D): |
$0.08 | 2.71%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.59M |
| Avg Daily Volume (30 D): |
1.08M |
| Avg Daily Volume (90 D): |
1.1M |
| Trade Size |
| Avg Trade Size (Sh.): |
174 |
| Avg Trade Size (Sh.) (30 D): |
128 |
| Avg Trade Size (Sh.) (90 D): |
142 |
| Institutional Trades |
| Total Inst.Trades: |
337 |
| Avg Inst. Trade: |
$1.69M |
| Avg Inst. Trade (30 D): |
$1.44M |
| Avg Inst. Trade (90 D): |
$1.2M |
| Avg Inst. Trade Volume: |
.44M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.97M |
| Avg Closing Trade (30 D): |
$1.52M |
| Avg Closing Trade (90 D): |
$1.35M |
| Avg Closing Volume: |
492.34K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.48
|
$-.12
|
$-.13
|
|
Diluted EPS
|
$-.48
|
$-.12
|
$-.13
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -102.17M
|
$ -26.64M
|
$ -29.04M
|
|
Operating Income / Loss
|
$ -109.16M
|
$ -28.44M
|
$ -31.17M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ 2.81M
|
$ 4.46M
|
$ -6.23M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Apr 28, 2017:
1:70
|
|
Apr 26, 2010:
1:25
|
|
Jul 26, 2000:
1:2
|
|
|
|
